Neutral
IDEXX Laboratories has raised its 2026 revenue and EPS targets after a strong first quarter, reporting approximately $1.14 billion in revenue, up 14% ...
Bullish
This article provides a long-term deep dive into IDEXX Laboratories, focusing on its business model, revenue drivers, and structural tailwinds in anim...
Neutral
Union Savings Bank acquired a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) in the fourth quarter, according to the company in ...
Neutral
Focus Partners Wealth boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 18.2% in the fourth quarter, according...
Bullish
IDEXX Laboratories Inc. (IDXX), a leader in veterinary diagnostics, continues to trade at premium valuation levels within the S&P 500 healthcare secto...
Bullish
IDEXX Laboratories reported strong Q1 2026 results with 14% revenue growth and gross margins reaching 63%, driven by increased diagnostic utilization ...